The global Lateral Flow Assay Components Market, valued at US$378.4 million in 2024, stood at US$392.4 million in 2025 and is ...

The global antibody testing market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the rising prevalence of ...

IPO candidate Nexsen hopes to revolutionise the market for real-time diagnostic testing, while eyeing fast-track FDA approval ...

PRNewswire/ -- "The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, ...

AUSTIN, Texas and TOKYO, Sept. 9, 2025 /PRNewswire/ -- "The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, and is expected ...

Microfluidic biosensors revolutionize diagnostics, providing portable, high-sensitivity tests for cancer and infections on ...

In an “historic moment in respiratory diagnostics”, the US Food & Drug Administration (FDA) has approved 4D Medical's (ASX:4DX) ventilation perfusion device, CT:VQ.

Dublin, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The "Lateral Flow Assays Market by Product (Kits, Readers), Application (STI, HEP, TB, Cardiac Marker, Pregnancy, Drug Abuse, Food Safety), Sample (Blood, ...

With diminished valuations but an unabated will to survive, pandemic-era 'hero' stocks have found other roads to follow. ... Read More The post Biocurious: Five years post-pandemic, the Covid ‘hero’ ...

In the fast-growing world of in vitro diagnostics (IVD), lateral flow assays (LFAs) have become a cornerstone for point-of-care testing. Their speed, simplicity, and versatility make them ideal for a ...

HENDERSON, Nev., July 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of ...